Robert Carter - Mar 31, 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role: Chief Financial Officer
Signature: /s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter
Stock symbol: TOI
Transactions as of: Mar 31, 2025
Transactions value $: $0
Form type: 4
Date filed: 4/2/2025, 05:22 PM
Previous filing: Mar 28, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TOI	Class A Common Stock	Award	$0	+197K	+500.85%	$0.00	237K	Mar 31, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents RSU awards with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

Content

Represents RSU awards with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.